719 related articles for article (PubMed ID: 17114344)
1. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
Buck A; Buchholz M; Wagner M; Adler G; Gress T; Ellenrieder V
Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344
[TBL] [Abstract][Full Text] [Related]
2. TGFbeta influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b.
Seoane J; Pouponnot C; Staller P; Schader M; Eilers M; Massagué J
Nat Cell Biol; 2001 Apr; 3(4):400-8. PubMed ID: 11283614
[TBL] [Abstract][Full Text] [Related]
3. Inability of transforming growth factor-beta to cause SnoN degradation leads to resistance to transforming growth factor-beta-induced growth arrest in esophageal cancer cells.
Edmiston JS; Yeudall WA; Chung TD; Lebman DA
Cancer Res; 2005 Jun; 65(11):4782-8. PubMed ID: 15930298
[TBL] [Abstract][Full Text] [Related]
4. Smad-Sp1 complexes mediate TGFbeta-induced early transcription of oncogenic Smad7 in pancreatic cancer cells.
Jungert K; Buck A; Buchholz M; Wagner M; Adler G; Gress TM; Ellenrieder V
Carcinogenesis; 2006 Dec; 27(12):2392-401. PubMed ID: 16714330
[TBL] [Abstract][Full Text] [Related]
5. Rap1 reverses transcriptional repression of TGF-beta type II receptor by a mechanism involving AP-1 in the human pancreatic cancer cell line, UK Pan-1.
Fralix KD; Zhao S; Venkatasubbarao K; Freeman JW
J Cell Physiol; 2003 Jan; 194(1):88-99. PubMed ID: 12447993
[TBL] [Abstract][Full Text] [Related]
6. KLF11 mediates a critical mechanism in TGF-beta signaling that is inactivated by Erk-MAPK in pancreatic cancer cells.
Ellenrieder V; Buck A; Harth A; Jungert K; Buchholz M; Adler G; Urrutia R; Gress TM
Gastroenterology; 2004 Aug; 127(2):607-20. PubMed ID: 15300592
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation regulates Myc expression via prolonged activation of the mitogen-activated protein kinase pathway.
Wang Z; Ge L; Wang M; Carr BI
J Cell Physiol; 2006 Jul; 208(1):133-40. PubMed ID: 16596619
[TBL] [Abstract][Full Text] [Related]
8. TGFbeta1 represses proliferation of pancreatic carcinoma cells which correlates with Smad4-independent inhibition of ERK activation.
Giehl K; Seidel B; Gierschik P; Adler G; Menke A
Oncogene; 2000 Sep; 19(39):4531-41. PubMed ID: 11002426
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.
Marampon F; Ciccarelli C; Zani BM
Mol Cancer; 2006 Aug; 5():31. PubMed ID: 16899113
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic Ras blocks transforming growth factor-beta-induced cell-cycle arrest by degradation of p27 through a MEK/Erk/SKP2-dependent pathway.
Schepers H; Wierenga AT; Eggen BJ; Vellenga E
Exp Hematol; 2005 Jul; 33(7):747-57. PubMed ID: 15963850
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.
Kinney EL; Tanida S; Rodrigue AA; Johnson JK; Tompkins VS; Sakamuro D
J Cell Physiol; 2008 Sep; 216(3):621-31. PubMed ID: 18348166
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta signaling via Ras in mesenchymal cells requires p21-activated kinase 2 for extracellular signal-regulated kinase-dependent transcriptional responses.
Suzuki K; Wilkes MC; Garamszegi N; Edens M; Leof EB
Cancer Res; 2007 Apr; 67(8):3673-82. PubMed ID: 17440079
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of the Carney complex gene 1 (protein kinase A regulatory subunit 1A) inhibits SMAD3 expression and TGF beta-stimulated apoptosis in adrenocortical cells.
Ragazzon B; Cazabat L; Rizk-Rabin M; Assie G; Groussin L; Fierrard H; Perlemoine K; Martinez A; Bertherat J
Cancer Res; 2009 Sep; 69(18):7278-84. PubMed ID: 19738044
[TBL] [Abstract][Full Text] [Related]
14. Cell growth suppression by thanatos-associated protein 11(THAP11) is mediated by transcriptional downregulation of c-Myc.
Zhu CY; Li CY; Li Y; Zhan YQ; Li YH; Xu CW; Xu WX; Sun HB; Yang XM
Cell Death Differ; 2009 Mar; 16(3):395-405. PubMed ID: 19008924
[TBL] [Abstract][Full Text] [Related]
15. Smad3 is a key nonredundant mediator of transforming growth factor beta signaling in Nme mouse mammary epithelial cells.
Dzwonek J; Preobrazhenska O; Cazzola S; Conidi A; Schellens A; van Dinther M; Stubbs A; Klippel A; Huylebroeck D; ten Dijke P; Verschueren K
Mol Cancer Res; 2009 Aug; 7(8):1342-53. PubMed ID: 19671686
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta inhibits telomerase through SMAD3 and E2F transcription factors.
Lacerte A; Korah J; Roy M; Yang XJ; Lemay S; Lebrun JJ
Cell Signal; 2008 Jan; 20(1):50-9. PubMed ID: 17881189
[TBL] [Abstract][Full Text] [Related]
17. pRb, Myc and p53 are critically involved in SV40 large T antigen repression of PDGF beta-receptor transcription.
Uramoto H; Hackzell A; Wetterskog D; Ballági A; Izumi H; Funa K
J Cell Sci; 2004 Aug; 117(Pt 17):3855-65. PubMed ID: 15265983
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness.
Gaspar NJ; Li L; Kapoun AM; Medicherla S; Reddy M; Li G; O'Young G; Quon D; Henson M; Damm DL; Muiru GT; Murphy A; Higgins LS; Chakravarty S; Wong DH
Mol Pharmacol; 2007 Jul; 72(1):152-61. PubMed ID: 17400764
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the antiproliferative effect of TGFbeta by EGF in primary human ovarian cancer cells.
Dunfield LD; Nachtigal MW
Oncogene; 2003 Jul; 22(30):4745-51. PubMed ID: 12879019
[TBL] [Abstract][Full Text] [Related]
20. Smad4 dependency defines two classes of transforming growth factor {beta} (TGF-{beta}) target genes and distinguishes TGF-{beta}-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses.
Levy L; Hill CS
Mol Cell Biol; 2005 Sep; 25(18):8108-25. PubMed ID: 16135802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]